Olson William C 4
4 · PROGENICS PHARMACEUTICALS INC · Filed Jun 22, 2012
Insider Transaction Report
Form 4
Olson William C
VP, Research & Development
Transactions
- Disposition to Issuer
Common Stock
2012-06-20$8.69/sh−1,230$10,685→ 45,544 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades at various price ranges. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.